William Chu - Concepedia

Author

William Chu

Sunnybrook Health Science Centre ORCID

Also Known As

Chu, Weihan, Chu, William, E Atenafu, W Chu, W. Chu, W.P. Chu, WILLIAM CHU, Weihan Chu, Weirong Chu, Wilbur Chu

280

Publications

5.2K

Citations

H-Index

124

Concepts

All Affiliations

Sunnybrook Health Science Centre University of Toronto Health Sciences Centre Princess Margaret Cancer Centre McMaster University

About

William Chu is an author at Sunnybrook Health Science Centre specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	30	54	2.7K
2	Health Sciences	16	21	679
3	Engineering	11	12	333
4	Public Health	3	3	324
5	Arts	1	1	11

William Chu

Publications

4.6K

Citations

H-Index

Page 1

	Year	Citations
Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity findings from an international, randomised, open-label, phase 3, non-inferiority trial Douglas Brand, Alison Tree, Peter Ostler, The Lancet Oncology	2019	519
BRCA1 and BRCA2 Mutation Analysis of 208 Ashkenazi Jewish Women with Ovarian Cancer Roxana Moslehi, William Chu, Beth Y. Karlan, The American Journal of Human Genetics Somatic VariantMedicinePathologyGynecologyBrca2 Mutation Analysis	2000	319
Intensity-modulated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): 2-year toxicity results from an open-label, randomised, phase 3, non-inferiority trial Alison Tree, Peter Ostler, H. van der Voet, The Lancet Oncology	2022	280
Genetic and nongenetic factors associated with variation of plasma levels of insulin-like growth factor-I and insulin-like growth factor-binding protein-3 in healthy premenopausal women. Helena Jernström, Cheri Deal, Françoise Wilkin, PubMed Human GrowthGenetic EpidemiologyReproductive HealthGynecologyIgf-i Levels	2001	182
Phase 3 Trial of Stereotactic Body Radiotherapy in Localized Prostate Cancer Nicholas van As, Clare Griffin, Alison Tree, New England Journal of Medicine	2024	172
Pooled analysis of stereotactic ablative radiotherapy for primary renal cell carcinoma: A report from the International Radiosurgery Oncology Consortium for Kidney (IROCK) Shankar Siva, Alexander V. Louie, Andrew Warner, Cancer	2017	161
Prostate high dose-rate brachytherapy as monotherapy for low and intermediate risk prostate cancer: Efficacy results from a randomized phase II clinical trial of one fraction of 19 Gy or two fractions of 13.5 Gy Gerard Morton, Merrylee McGuffin, Hans T. Chung, Radiotherapy and Oncology UrologyRadiation TherapyMedicineBrachytherapyProstatic Disease	2020	127
Stereotactic Radiotherapy for Oligoprogression in Metastatic Renal Cell Cancer Patients Receiving Tyrosine Kinase Inhibitor Therapy: A Phase 2 Prospective Multicenter Study Patrick Cheung, Samir Patel, Scott North, European Urology UrologyRadiation TherapyGenitourinary CancerMedicineProspective Multicenter Study	2021	118
Stratospheric ozone profile and total ozone trends derived from the SAGE I and SAGE II data M. P. McCormick, Robert E. Veiga, William Chu Geophysical Research Letters Sage Ii DataEngineeringAtmospheric ModelEarth ScienceAtmospheric Science	1992	110
Genetic Factors Related to Racial Variation in Plasma Levels of Insulin-Like Growth Factor-1: Implications for Premenopausal Breast Cancer Risk Helena Jernström, William Chu, Danny Vesprini, Molecular Genetics and Metabolism EpidemiologyBreast OncologyCancer EpidemiologyEndocrine-related CancerPlasma Levels	2001	110

Page 1